Registro:

Referencias:

• De La Torre, P.M., Enobakhare, Y., Torrado, G., Torrado, S., Release of amoxicillin from polyionic complexes of chitosan and poly(acrylic acid) study of polymer/polymer and polymer/drug interactions within the network structure (2003) Biomaterials, 24 (8), pp. 1499-1506. , DOI 10.1016/S0142-9612(02)00512-4, PII S0142961202005124
• Dulong, V., Lack, S., Le Cerf, D., Picton, L., Vannier, J.P., Muller, G., Hyaluronan-based hydrogels particles prepared by crosslinking with trisodium trimetaphosphate. Synthesis and characterization (2004) Carbohydr. Polym., 57, pp. 1-6
• Hennink, W.E., Van Nostrum, C.F., Novel crosslinking methods to design hydrogels (2002) Advanced Drug Delivery Reviews, 54 (1), pp. 13-36. , DOI 10.1016/S0169-409X(01)00240-X, PII S0169409X0100240X
• Higgins, J.D., Gilmor, T.P., Martellucci, S.A., Bruce, R.D., Brittain, H.G., Ibuprofen (2001) Profiles of Drug Substances, Excipients and Related Methodology, 27, pp. 265-300. , PII S1075628001270086
• Huang, X., Brazel, C.S., On the importance and mechanisms of burst release in matrix-controlled drug delivery systems (2001) Journal of Controlled Release, 73 (2-3), pp. 121-136. , DOI 10.1016/S0168-3659(01)00248-6, PII S0168365901002486
• Lieberman, H.A., Lachman, L., (1980) Pharmaceutical Dosage Forms: Tablets, , Marcel Dekker, Inc. New York
• Lowman, A.M., Complexing polymers in drug delivery (2000) Handbook of Pharmaceutical Controlled Release Technology, pp. 89-98. , D.L. Wise, Marcel Dekker New York
• Meshali, M.M., Gabr, K.E., Effect of interpolymer complex formation of chitosan with pectin or acacia on the release behaviour of chlorpromazine HCl (1993) International Journal of Pharmaceutics, 89 (3), pp. 177-181. , DOI 10.1016/0378-5173(93)90241-7
• Moustafine, R.I., Kabanova, T.V., Kemenova, V.A., Van Den Mooter, G., Characteristics of interpolyelectrolyte complexes of Eudragit E100 with Eudragit L100 (2005) Journal of Controlled Release, 103 (1), pp. 191-198. , DOI 10.1016/j.jconrel.2004.11.031, PII S016836590400598X
• Moustafine, R.I., Kemenova, V.A., Van Den Mooter, G., Characteristics of interpolyelectrolyte complexes of Eudragit E 100 with sodium alginate (2005) International Journal of Pharmaceutics, 294 (1-2), pp. 113-120. , DOI 10.1016/j.ijpharm.2005.01.029
• Moustafine, R.I., Zaharov, I.M., Kemenova, V.A., Physicochemical characterization and drug release properties of Eudragit® e PO/Eudragit® L 100-55 interpolyelectrolyte complexes (2006) Eur. J. Pharm. Biopharm., 63, pp. 26-36
• Moustafine, R.I., Margulis, E.B., Sibgatullina, L.F., Kemenova, V.A., Van Den Mooter, G., Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit® L100 and Eudragit® L100-55 as potential carriers for oral controlled drug delivery (2008) Eur. J. Pharm. Biopharm., 70, pp. 215-225
• Moustafine, R.I., Salachova, A.R., Frolova, E.S., Kemenova, V.A., Van Den Mooter, G., Interpolyelectrolyte complexes of Eudragit® e PO with sodium alginate as potential carriers for colonic drug delivery: Monitoring of structural transformation and composition changes during swellability and release evaluating (2009) Drug Dev. Ind. Pharm., 35, pp. 1439-1451
• Park, S.H., Chun, M.K., Choi, H.K., Preparation of an extended-release matrix tablet using chitosan/carbopol interpolymer complex (2008) Int. J. Pharm., 347, pp. 39-44
• Peppas, N.A., Analysis of Fickian and non-Fickian drug release from polymers (1985) Pharm. Acta Helv., 60, pp. 110-115
• Peppas, N.A., Bures, P., Leobandung, W., Ichikawa, H., Hydrogels in pharmaceutical formulations (2000) European Journal of Pharmaceutics and Biopharmaceutics, 50 (1), pp. 27-46. , DOI 10.1016/S0939-6411(00)00090-4, PII S0939641100000904
• Prado, H.J., Ciancia, M., Matulewicz, M.C., Agarans from the red seaweed Polysiphonia nigrescens (Rhodomelaceae, Ceramiales) (2008) Carbohydr. Res., 343, pp. 711-718
• Prado, H.J., Matulewicz, M.C., Bonelli, P., Cukierman, A.L., Basic butylated methacrylate copolymer/kappa-carrageenan interpolyelectrolyte complex: Preparation, characterization and drug release behaviour (2008) Eur. J. Pharm. Biopharm., 70, pp. 171-178
• Prado, H.J., Matulewicz, M.C., Bonelli, P.R., Cukierman, A.L., Preparation and characterization of a novel starch-based interpolyelectrolyte complex as matrix for controlled drug release (2009) Carbohydr. Res., 344, pp. 1325-1331
• Prado, H.J., Matulewicz, M.C., Bonelli, P.R., Cukierman, A.L., Studies on the cationization of agarose (2011) Carbohydr. Res., 346, pp. 311-321
• Satish, C., Satish, K., Shivakumar, H., Hydrogels as controlled drug delivery systems: Synthesis, crosslinking, water and drug transport mechanism (2006) Indian Journal of Pharmaceutical Sciences, 68 (2), pp. 133-140
• Siepmann, J., Peppas, N.A., Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC) (2001) Advanced Drug Delivery Reviews, 48 (2-3), pp. 139-157. , DOI 10.1016/S0169-409X(01)00112-0, PII S0169409X01001120
• Singh, S.K., Naini, V., Dosage forms: Non-parenterals (2007) Encyclopedia of Pharmaceutical Technology, pp. 988-1000. , J. Swarbrick, third ed. Informa Healthcare New York
• Tapia, C., Costa, E., Moris, M., Sapag-Hagar, J., Valenzuela, F., Basualto, C., Study of the influence of the pH media dissolution, degree of polymerization, and degree of swelling of the polymers on the mechanism of release of diltiazem from matrices based on mixtures of chitosan/alginate (2002) Drug Development and Industrial Pharmacy, 28 (2), pp. 217-224. , DOI 10.1081/DDC-120002455
• Tapia, C., Escobar, Z., Costa, E., Sapag-Hagar, J., Valenzuela, F., Basualto, C., Gai, M.N., Yazdani-Pedram, M., Comparative studies on polyelectrolyte complexes and mixtures of chitosan-alginate and chitosan-carrageenan as prolonged diltiazem clorhydrate release systems (2004) European Journal of Pharmaceutics and Biopharmaceutics, 57 (1), pp. 65-75. , DOI 10.1016/S0939-6411(03)00153-X
• Thünemann, A., Müller, M., Dautzenberg, H., Joanny, J., Löwen, H., Polyelectrolyte complexes (2004) Adv. Pol. Sci., 166, pp. 113-171. , M. Schmidt, Springer-Verlag Berlin
• (2007) The United States Pharmacopeia 30/National Formulary 25, , USP 30/NF 25 United States Pharmacopeial Convention, Inc. USA

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------